Inc., and Vice President at GSK plc (formerly GlaxoSmithKline plc) and Kos Pharmaceuticals, Inc. Notable achievements include building an $800M division at Kos Pharmaceuticals, Inc., helping ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

Leading pharmaceutical companies such as Mylan Pharmaceuticals Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and many others are actively involved in developing innovative ...

GSK PLC closed 30.68% below its 52-week high of £18.24, which the company achieved on May 16th.

Shares of GSK PLC GSK slipped 6.07% to £13.32 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 4.38% to 7,702.08. GSK PLC ...

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2916. The stock has experienced fluctuations tod ...

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated ...